
D-AP5, Tocris Bioscience™
CAS: 79055-68-8 Summenformel: C5H12NO5P Molekulargewicht (g/mol): 197.127 InChI-Schlüssel: VOROEQBFPPIACJ-SCSAIBSYSA-N Synonym: d-ap5,5-phosphono-d-norvaline,d-norvaline, 5-phosphono,d-apv,2r-2-amino-5-phosphonopentanoic acid,d-2-amino-5-phosphopentanoic acid,d---2-amino-5-phosphonopentanoic acid,d--apv,d-2-amino-5-phosphonovaleric acid,d--ap-5 PubChem CID: 135342 IUPAC-Name: (2R)-2-Amino-5-phosphonpentansäure SMILES: C(CC(C(=O)O)N)CP(=O)(O)O
InChI-Schlüssel | VOROEQBFPPIACJ-SCSAIBSYSA-N |
---|---|
IUPAC-Name | (2R)-2-Amino-5-phosphonpentansäure |
PubChem CID | 135342 |
CAS | 79055-68-8 |
Molekulargewicht (g/mol) | 197.127 |
SMILES | C(CC(C(=O)O)N)CP(=O)(O)O |
Synonym | d-ap5,5-phosphono-d-norvaline,d-norvaline, 5-phosphono,d-apv,2r-2-amino-5-phosphonopentanoic acid,d-2-amino-5-phosphopentanoic acid,d---2-amino-5-phosphonopentanoic acid,d--apv,d-2-amino-5-phosphonovaleric acid,d--ap-5 |
Summenformel | C5H12NO5P |
R&D Systems™ Recombinant Human FSH alpha/beta Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
---|---|
Rekombinant | Recombinant |
Molekulargewicht | 10.2 kDa (FSH alpha) & 12.4 kDa (FSH beta) |
Konjugat | Unconjugated |
Menge | 10 μg |
Strukturform | Noncovalently-linked heterodimer |
Quelle | Chinese Hamster Ovary cell line,CHO-derived human FSH alpha/beta protein, (N-terminus) Human FSH alpha Ala25-Ser116 Accession &Num; P01215 Human FSH beta Cys21-Glu129 Accession &Num; P01225 (C-terminus) |
Reinheits- oder Qualitätsgrad | 95%, by SDS-PAGE with silver staining. |
Name | FSH alpha/beta |
Gen-ID (Entrez) | 2488 |
R&D Systems™ Recombinant Human Integrin alpha 4 beta 7 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human Glucosamine (N-acetyl)-6-Sulfatase
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Mouse Integrin alpha 2 beta 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
R&D Systems™ Recombinant Mouse beta IG-H3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
ML 141, Tocris Bioscience™
CAS: 71203-35-5 Summenformel: C22H21N3O3S Molekulargewicht (g/mol): 407.488 InChI-Schlüssel: QBNZBMVRFYREHK-UHFFFAOYSA-N Synonym: 4-3-4-methoxyphenyl-5-phenyl-3,4-dihydropyrazol-2-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydropyrazol-1-yl benzenesulfonamide,cid,ml hplc,4-5-4-methoxyphenyl-3-phenyl-2-pyrazolinyl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-2-pyrazolin-1-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydro-1hpyrazol-1-yl benzenesulfonamide,4-4,5-dihydro-5-4-methoxyphenyl-3-phenyl-1h-pyrazol-1-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl benzene-1-sulfonamide PubChem CID: 2950007 IUPAC-Name: 4-[3-(4-methoxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide SMILES: COC1=CC=C(C=C1)C2CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C4=CC=CC=C4
InChI-Schlüssel | QBNZBMVRFYREHK-UHFFFAOYSA-N |
---|---|
IUPAC-Name | 4-[3-(4-methoxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide |
PubChem CID | 2950007 |
CAS | 71203-35-5 |
Molekulargewicht (g/mol) | 407.488 |
SMILES | COC1=CC=C(C=C1)C2CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C4=CC=CC=C4 |
Synonym | 4-3-4-methoxyphenyl-5-phenyl-3,4-dihydropyrazol-2-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydropyrazol-1-yl benzenesulfonamide,cid,ml hplc,4-5-4-methoxyphenyl-3-phenyl-2-pyrazolinyl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-2-pyrazolin-1-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydro-1hpyrazol-1-yl benzenesulfonamide,4-4,5-dihydro-5-4-methoxyphenyl-3-phenyl-1h-pyrazol-1-yl benzenesulfonamide,4-5-4-methoxyphenyl-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl benzene-1-sulfonamide |
Summenformel | C22H21N3O3S |
NF 110, Tocris Bioscience™
CAS: 111150-22-2 Summenformel: C41H28N6Na4O17S4 Molekulargewicht (g/mol): 1096.899 InChI-Schlüssel: AQJHZNCSXLBXMY-UHFFFAOYSA-J Synonym: 4,4',4,4'-carbonylbis imino-5,1,3-benzenetriylbis carbonylimino tetrakisbenzenesulfonic acid tetrasodium salt,benzenesulfonic acid,4,4',4,4'-carbonylbis imino-5,1,3-benzenetriylbis carbonylimino tetrakis-,tetrasodium salt 9ci,tetrasodium 4-3-3,5-bis 4-sulfonatophenyl carbamoyl phenyl carbamoyl amino-5-4-sulfonatophenyl carbamoyl benzamido benzenesulfonate PubChem CID: 16066783 IUPAC-Name: tetrasodium;4-[[3-[[3,5-bis[(4-sulfonatophenyl)carbamoyl]phenyl]carbamoylamino]-5-[(4-sulfonatophenyl)carbamoyl]benzoyl]amino]benzenesulfonate SMILES: C1=CC(=CC=C1NC(=O)C2=CC(=CC(=C2)NC(=O)NC3=CC(=CC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)(=O)[O-])C(=O)NC5=CC=C(C=C5)S(=O)(=O)[O-])C(=O)NC6=CC=C(C=C6)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+]
InChI-Schlüssel | AQJHZNCSXLBXMY-UHFFFAOYSA-J |
---|---|
IUPAC-Name | tetrasodium;4-[[3-[[3,5-bis[(4-sulfonatophenyl)carbamoyl]phenyl]carbamoylamino]-5-[(4-sulfonatophenyl)carbamoyl]benzoyl]amino]benzenesulfonate |
PubChem CID | 16066783 |
CAS | 111150-22-2 |
Molekulargewicht (g/mol) | 1096.899 |
SMILES | C1=CC(=CC=C1NC(=O)C2=CC(=CC(=C2)NC(=O)NC3=CC(=CC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)(=O)[O-])C(=O)NC5=CC=C(C=C5)S(=O)(=O)[O-])C(=O)NC6=CC=C(C=C6)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+] |
Synonym | 4,4',4,4'-carbonylbis imino-5,1,3-benzenetriylbis carbonylimino tetrakisbenzenesulfonic acid tetrasodium salt,benzenesulfonic acid,4,4',4,4'-carbonylbis imino-5,1,3-benzenetriylbis carbonylimino tetrakis-,tetrasodium salt 9ci,tetrasodium 4-3-3,5-bis 4-sulfonatophenyl carbamoyl phenyl carbamoyl amino-5-4-sulfonatophenyl carbamoyl benzamido benzenesulfonate |
Summenformel | C41H28N6Na4O17S4 |
AQ-RA 741, Tocris Bioscience™
CAS: 123548-16-3 Summenformel: C27H37N5O2 Molekulargewicht (g/mol): 463.626 InChI-Schlüssel: BCUGCHZRMKTPMU-UHFFFAOYSA-N Synonym: aq-ra 741,aq-ra-741,11-4-4-diethylamino butyl-1-piperidinyl acetyl-5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-one,6h-pyrido 2,3-b 1,4 benzodiazepin-6-one,11-2-4-4-diethylamino butyl-1-piperidinyl acetyl-5,11-dihydro,acmc-20ej93,d0vz3d,aq-ra-741bs,chembl43383,11-2-4-4-diethylamino butyl piperidin-1-yl acetyl-5h-benzo e pyrido 3,2-b 1,4 diazepin-6 11h-one PubChem CID: 129989 IUPAC-Name: 11-[2-[4-[4-(diethylamino)butyl]piperidin-1-yl]acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one SMILES: CCN(CC)CCCCC1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4
InChI-Schlüssel | BCUGCHZRMKTPMU-UHFFFAOYSA-N |
---|---|
IUPAC-Name | 11-[2-[4-[4-(diethylamino)butyl]piperidin-1-yl]acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one |
PubChem CID | 129989 |
CAS | 123548-16-3 |
Molekulargewicht (g/mol) | 463.626 |
SMILES | CCN(CC)CCCCC1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4 |
Synonym | aq-ra 741,aq-ra-741,11-4-4-diethylamino butyl-1-piperidinyl acetyl-5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-one,6h-pyrido 2,3-b 1,4 benzodiazepin-6-one,11-2-4-4-diethylamino butyl-1-piperidinyl acetyl-5,11-dihydro,acmc-20ej93,d0vz3d,aq-ra-741bs,chembl43383,11-2-4-4-diethylamino butyl piperidin-1-yl acetyl-5h-benzo e pyrido 3,2-b 1,4 diazepin-6 11h-one |
Summenformel | C27H37N5O2 |
CI 976, Tocris Bioscience™
CAS: 114289-47-3 Summenformel: C23H39NO4 Molekulargewicht (g/mol): 393.568 InChI-Schlüssel: WAFNZAURAWBNDZ-UHFFFAOYSA-N Synonym: 2,2-dimethyl-n-2,4,6-trimethoxyphenyl dodecanamide,chembl22373,unii-8653iq20ea,dodecanamide,2,2-dimethyl-n-2,4,6-trimethoxyphenyl,dodecanamide, 2,2-dimethyl-n-2,4,6-trimethoxyphenyl,2,2-dimethyl-dodecanoic acid 2,4,6-trimethoxy-phenyl-amide,acmc-1cuxf,d0d1xg,ci hplc , solid PubChem CID: 122327 IUPAC-Name: 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide SMILES: CCCCCCCCCCC(C)(C)C(=O)NC1=C(C=C(C=C1OC)OC)OC
InChI-Schlüssel | WAFNZAURAWBNDZ-UHFFFAOYSA-N |
---|---|
IUPAC-Name | 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide |
PubChem CID | 122327 |
CAS | 114289-47-3 |
Molekulargewicht (g/mol) | 393.568 |
SMILES | CCCCCCCCCCC(C)(C)C(=O)NC1=C(C=C(C=C1OC)OC)OC |
Synonym | 2,2-dimethyl-n-2,4,6-trimethoxyphenyl dodecanamide,chembl22373,unii-8653iq20ea,dodecanamide,2,2-dimethyl-n-2,4,6-trimethoxyphenyl,dodecanamide, 2,2-dimethyl-n-2,4,6-trimethoxyphenyl,2,2-dimethyl-dodecanoic acid 2,4,6-trimethoxy-phenyl-amide,acmc-1cuxf,d0d1xg,ci hplc , solid |
Summenformel | C23H39NO4 |
R&D Systems™ Recombinant Mouse beta-Defensin 3 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human Integrin alpha 6 (X1) beta 4 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
R&D Systems™ Recombinant Human Latent TGF-beta 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Lagerungsbedingungen | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, ≤ -20° C under sterile conditions after opening. |
---|---|
Rekombinant | Recombinant |
Molekulargewicht | Observed Molecular Wt: 40-43kDa & 12kDa, reducing conditions 80-90kDa, non-reducing conditions, Predicted Molecular Wt.: 41.3kDa (monomer) |
Konjugat | Unconjugated |
Endotoxin-Konzentration | <1.0 EU per 1μg of the protein by the LAL method. |
Gen-Alias | CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 |
Quelle | Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 1 protein Leu30-Ser390 |
Reinheits- oder Qualitätsgrad | 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Name | Latent TGF-beta 1 |
Gen-ID (Entrez) | 7040 |